Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 64 (RPL7AP64)

Target: RPL7AP64
Molecular classification: Other (pseudogene; not a member of a druggable or expressed molecular family)

Overview

Ribosomal protein L7a pseudogene 64 (RPL7AP64) is a human processed pseudogene related to the gene encoding ribosomal protein L7a (RPL7A), which is a component of the 60S subunit of cytoplasmic ribosomes. Unlike the functional gene, pseudogenes like RPL7AP64 generally do not encode functional proteins, are not transcribed, and have no known biological activity or role in disease. They are considered genomic relics of duplicated or retrotransposed gene copies that have lost coding capability[7][5][4].

Other names: RPL7AP64RPL7A_29_1509Ribosomal protein L7a pseudogene 64Human RPL7AP64HGNC: 35821Ensembl: ENSG00000213876NCBI Gene: 728486

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 64 (RPL7AP64).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 64 (RPL7AP64).

Explore the full profile